Cystic fibrosis drugs rejected for use by NHS in Scotland

BBC News

12 August 2019 - Two "life-changing" cystic fibrosis drugs have been rejected for routine use by the NHS in Scotland.

The Scottish Medicines Consortium said there were uncertainties about the long-term health benefits of Orkambi and Symkevi in relation to their costs.

Manufacturer Vertex and the Scottish government are now working "as a matter of urgency" to find a way to allow broad access for eligible patients.

Read BBC News article

Michael Wonder

Posted by:

Michael Wonder